Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v54-FR | Version v31-FR | |
---|---|---|
Language | French | French |
Date Updated | 2023-03-02 | 2018-12-10 |
Drug Identification Number | 02457431 | 02457431 |
Brand name | ERFA-TRANEXAMIC | ERFA-TRANEXAMIC |
Common or Proper name | TRANEXAMIC ACID IV | TRANEXAMIC ACID IV |
Company Name | SEARCHLIGHT PHARMA INC | SEARCHLIGHT PHARMA INC |
Ingredients | TRANEXAMIC ACID | TRANEXAMIC ACID |
Strength(s) | 100 mg/mL | 100 mg/mL |
Dosage form(s) | Solution | Solution |
Route of administration | Intravenous | Intravenous |
Packaging size | vial | vial |
ATC code | B02AA | B02AA |
ATC description | Antifibrinolytics | Antifibrinolytics |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | ||
Actual start date | 2018-04-25 | 2018-04-25 |
Estimated end date | Unknown | 2019-02-15 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | FYI- Erfa Tranexamic acid 100 MG/ml -1 vial of 50 ml to be available in March 2019 . Pack of 10 vial of 5 mL and 10 vial of 10 ml to be available in February 2019 due to product recall. | |
Health Canada comments |